Vaccines

Cell Bank Characterization

GMP-compliant testing for master and working cell banks, including sterility, mycoplasma, adventitious agents and species identity.

Explore Cell Line Characterization

Assay Development & Transfer

Design and validation of phase-appropriate assays in accordance with FDA and EMA expectations.

See Analytical Development

Viral Clearance Studies

Thoughtful and innovative study design with high-titer virus stocks and optimized spiking strategies to maximize viral clearance log reduction values (LRVs).

See Viral Clearance Studies

Lot Release Testing

Biosafety, purity, identity, and potency assays tailored to vaccines support global clinical trials and commercial supply.

Explore Lot Release Testing

Stability Programs

ICH-compliant stability studies to establish shelf life and support formulation changes.

Learn About Stability Studies
Advanced Testing Support for Viral and
Protein-Based Vaccines

Minaris Advanced Testing, with over 40 years of expertise in biosafety and analytical testing, is a trusted partner for vaccine characterization and lot release.

Global Reach, Regulatory Confidence

The FDA- and EMA-certified, state-of-the-art facility in Philadelphia, Pennsylvania, offers both regional access and global capacity. Our unified quality systems, proven regulatory track record and integrated QC testing ensure confidence at every phase, from early development through commercial launches.

Contact Us

Minaris Advanced Therapies is dedicated to helping innovators in cell and gene therapy succeed. Whether you are in early-stage development or preparing for commercial launch, our end-to-end expertise, global reach and commitment to quality make us the ideal partner for cell and gene therapy manufacturing and GMP biosafety and analytical testing of all biologics.